Santosa, Ailiana
Franzén, Stefan
Nåtman, Jonatan
Wettermark, Björn
Parmryd, Ingela
Nyberg, Fredrik
Funding for this research was provided by:
The ALF-agreement (ALFGBG-938453, ALFGBG-971130)
FORMAS (2020-02828)
The Swedish Heart Lung Foundation (20210030, 20210581)
University of Gothenburg
Article History
Received: 8 March 2022
Accepted: 8 July 2022
First Online: 14 July 2022
Competing interests
: FN reports prior employment at AstraZeneca until 2019, and ownership of some AstraZeneca shares. SF is currently employed at AstraZeneca. IP reports ownership of some AstraZeneca shares. AS, BW, and JN have nothing to disclose.